Green synthesis and evaluation of silver nanoparticles as adjuvant in rabies veterinary vaccine

References

• FinkeSConzelmannKKReplication strategies of rabies virusVirus Res2005111212013115885837
   PubMedGoogle Scholar
• BahloulCTaiebDKaabiBComparative evaluation of specific ELISA and RFFIT antibody assays in the assessment of dog immunity against rabiesEpidemiol Infect2005133474975716050522
   PubMedGoogle Scholar
• KnobelDLCleavelandSColemanPGRe-evaluating the burden of rabies in Africa and AsiaBull World Health Organ200583536036815976877
   PubMed Web of Science ®Google Scholar
• MooreSMHanlonCARabies-specific antibodies: measuring surrogates of protection against a fatal diseasePLoS Negl Trop Dis201043e59520231877
   PubMed Web of Science ®Google Scholar
• FinneganCJBrookesSMJohnsonNRabies in North America and EuropeJ R Soc Med200295191311773344
   PubMedGoogle Scholar
• LindbladEBAluminium compounds for use in vaccinesImmunol Cell Biol200482549750515479435
   PubMed Web of Science ®Google Scholar
• WangWSinghMSelection of adjuvants for enhanced vaccine potencyWorld J Vaccines2011123378
   Google Scholar
• SivakumarSMSafhiMMKannadasanMSukumaranNVaccine adjuvants – current status and prospects on controlled release adjuvancitySaudi Pharm J201119419720623960760
   PubMedGoogle Scholar
• PetrovskyNAguilarJCVaccine adjuvants: current state and future trendsImmunol Cell Biol200482548849615479434
   PubMed Web of Science ®Google Scholar
• HeQMitchellARJohnsonSLWagner-BartakCMorcolTBellSJCalcium phosphate nanoparticle adjuvantClin Diagn Lab Immunol20007689990311063495
   PubMedGoogle Scholar
• ZhaoLSethAWibowoNNanoparticle vaccinesVaccine201432332733724295808
   PubMed Web of Science ®Google Scholar
• DykmanLAStaroverovSABogatyrevVAShchyogolevSYAdjuvant properties of gold nanoparticlesNanotechnol Russ2010511–12748761
   Google Scholar
• XuYTangHLiuJHWangHLiuYEvaluation of the adjuvant effect of silver nanoparticles both in vitro and in vivoToxicol Lett20132191424823454833
   PubMed Web of Science ®Google Scholar
• AkagiTBabaMAkashiMBiodegradable nanoparticles as vaccine adjuvants and delivery systems: regulation of immune responses by nanoparticle-based vaccineKunugiSYamaokaTPolymers in Nanomedicine247Berlin, HeidelbergSpringer20123164
   Google Scholar
• MalyalaPSinghMMicro/nanoparticle adjuvants: preparation and formulation with antigensDaviesGVaccine Adjuvants: Methods and ProtocolsTotowa, NJHumana Press201091101
   Google Scholar
• HorikoshiSSerponeNIntroduction to nanoparticlesMicrowaves in Nanoparticle SynthesisWeinheimWiley-VCH Verlag GmbH & Co. KGaA2013124
   Google Scholar
• Rahimi-NasrabadiMCohanRASadat ShandizSAOptimization of biological synthesis of silver nanoparticles using plant extract of EucalyptusThe Third Congress of Defense Applications of NanoscienceTehranImam Hossein University2013
   Google Scholar
• ReedLJMuenchHA simple method of estimating fifty per cent endpointsAm J Epidemiol1938273493497
   Google Scholar
• MeslinF-XKaplanMMKoprowskiHOrganizationWHLaboratory Techniques in RabiesGenevaCiteseer1996
   Google Scholar
• CommissionBPCouncilGMCommissionGBMBritish PharmacopoeiaLondonHer Majesty’s Stationery Office2015
   Google Scholar
• Pharmacopoeia CotEoaERabies Vaccine (Inactivated) for Veterinary UseStrasbourgCouncil of Europe2015
   Google Scholar
• Pharmacopeia USUSP 38–NF 33US Pharmacopeial ConventionRockville, MD2015
   Google Scholar
• AldingerKASokoloffGRosenbergDMPalmerAAMillenKJGenetic variation and population substructure in outbred CD-1 mice: implications for genome-wide association studiesPLoS One200943e472919266100
   PubMedGoogle Scholar
• Fillman-HollidayDEverittJAnimal care and use in toxicity testingMcQueenCAComprehensive Toxicology (Second Edition)OxfordElsevier201097115
   Google Scholar
• MooreGEGuptillLFWardMPAdverse events diagnosed within three days of vaccine administration in dogsJ Am Vet Med Assoc200522771102110816220670
   PubMed Web of Science ®Google Scholar
• DunnJGormanNBSAVA EDUCATION COMMITTEE COMMISSIONED ARTICLE Fever of unknown origin in dogs and catsJ Small Anim Pract1987283167181
   Google Scholar
• De JongWHBormPJDrug delivery and nanoparticles: applications and hazardsInt J Nanomedicine20083213314918686775
   PubMed Web of Science ®Google Scholar
• BrownPKQureshiATMollANHayesDJMonroeWTSilver nanoscale antisense drug delivery system for photoactivated gene silencingACS Nano2013742948295923473419
   PubMedGoogle Scholar
• VermaAStellacciFEffect of surface properties on nanoparticle-cell interactionsSmall201061122119844908
   PubMed Web of Science ®Google Scholar
• SaptarshiSRDuschlALopataALInteraction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticleJ Nanobiotechnology20131112623870291
   PubMedGoogle Scholar
• WatanabeHNumataKItoTTakagiKMatsukawaAInnate immune response in Th1- and Th2-dominant mouse strainsShock200422546046615489639
   PubMed Web of Science ®Google Scholar
• ParkEJBaeEYiJRepeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticlesEnviron Toxicol Pharmacol201030216216821787647
   PubMed Web of Science ®Google Scholar
• ParkJLimDHLimHJSize dependent macrophage responses and toxicological effects of Ag nanoparticlesChem Commun (Camb)201147154382438421390403
   PubMed Web of Science ®Google Scholar